Growth hormone axis in cushing's syndrome.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Hormone Research

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1159/000184767PMID 8742127
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inhibition of growth hormone release after the combined administration of CHRH and GHRP‐6 in patients with Cushing's syndrome

  1994cited by this paper
• Functional analysis of glucocorticoid and insulin response sequences in the rat insulin-like growth factor-binding protein-1 promoter.

  1994cited by this paper
• Nutritional regulation of the insulin-like growth factors.

  1994cited by this paper
• Suppressed spontaneous and stimulated growth hormone secretion in patients with Cushing's disease before and after surgical cure.

  1994cited by this paper
• Once is not enough--promiscuity begets diversity among the insulin-like growth factor binding proteins.

  1994cited by this paper
• Insulin-like growth factor (IGF) I and II and IGF binding protein (IGFBP) 1, 2 and 3 in serum from patients with Cushing's syndrome.

  1993cited by this paper
• Clinical applications of IGFBP-1 and its regulation.

  1993cited by this paper
• Circulating binding proteins for the insulinlike growth factors.

  1993cited by this paper
• A new dimension on the induced release of growth hormone in obese subjects.

  1993cited by this paper
• Growth hormone releasing hormone priming increases growth hormone secretion in patients with Cushing's syndrome

  1993cited by this paper
• Different effects of pyridostigmine on growth hormone (GH) response to GH-releasing hormone in endogenous and exogenous hypercortisolemic patients.

  1993cited by this paper
• The distal axis of growth hormone (GH) in nutritional disorders: GH-binding protein, insulin-like growth factor-I (IGF-I), and IGF-I receptors in obesity and anorexia nervosa.

  1992cited by this paper
• Physiology of growth hormone secretion and action.

  1992cited by this paper
• Neuroendocrine control of growth hormone secretion in humans.

  1992cited by this paper
• The role of body mass in the response to growth hormone therapy.

  1992cited by this paper
• The insulin-like growth factor binding protein-1 in low and high insulin responders before and during dexamethasone treatment.

  1991cited by this paper
• Growth hormone-binding protein activity is inversely related to 24-hour growth hormone release in normal boys.

  1991cited by this paper
• IGFBP-1. Production and control mechanisms.

  1991cited by this paper
• Growth hormone (GH)-releasing peptide stimulates GH release in normal men and acts synergistically with GH-releasing hormone.

  1990cited by this paper
• Antitumor promotion and antiinflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone.

  1990cited by this paper
• Growth hormone gene regulation: a paradigm for cell-type-specific gene activation.

  1990cited by this paper
• Acute administration of corticoids: a new and peculiar stimulus of growth hormone secretion in man.

  1990cited by this paper
• Cholinergic receptor activation by pyridostigmine restores growth hormone (GH) responsiveness to GH-releasing hormone administration in obese subjects: evidence for hypothalamic somatostatinergic participation in the blunted GH release of obesity.

  1989cited by this paper
• Lack of diurnal rhythm of low molecular weight insulin-like growth factor binding protein in patients with Cushing's disease.

  1989cited by this paper
• REDUCED GROWTH HORMONE RESPONSE TO GROWTH HORMONE‐RELEASING HORMONE IN CHILDREN WITH SIMPLE OBESITY: EVIDENCE FOR SOMATOMEDIN‐C MEDIATED INHIBITION

  1987cited by this paper
• Analysis of serum insulin-like growth factor binding proteins using western blotting: use of the method for titration of the binding proteins and competitive binding studies.

  1986cited by this paper
• Growth hormone-releasing factor binding sites in rat anterior pituitary membrane homogenates: modulation by glucocorticoids.

  1985cited by this paper
• Glucocorticoid effects on somatomedins and somatomedin inhibitors.

  1985cited by this paper
• Stimulation of growth hormone (GH) and somatomedin C in idiopathic GH-deficient subjects by intermittent pulsatile administration of synthetic human pancreatic tumor GH-releasing factor.

  1984cited by this paper
• Glucocorticoid and thyroid hormones transcriptionally regulate growth hormone gene expression.

  1982cited by this paper
• Serum somatomedin/insulin-like growth factor (IGF) and IGF carrier levels in patients with Cushing's syndrome or receiving glucocorticoid therapy.

  1982cited by this paper

• The utility of IGF1 in the evaluation of pediatric patients with endogenous hypercortisolemia

  2023cites this paper
• Dexamethasone Rescues an Acute High-Fat Diet-Induced Decrease in Human Growth Hormone Gene Expression in Male Partially Humanized CD-1 Mice

  2021cites this paper
• The association between insulin-like growth factor 1 levels within reference range and early postoperative remission rate in patients with Cushing’s disease

  2021cites this paper
• Lipectomy associated to obesity produces greater fat accumulation in the visceral white adipose tissue of female compared to male rats

  2019cites this paper
• Elevated insulin‐like growth factor‐1 in Cushing’s disease

  2019cites this paper
• A useful model to compare human and mouse growth hormone gene chromosomal structure, expression and regulation, and immune tolerance of human growth hormone analogues.

  2018cites this paper
• Growth hormone and insulin-like growth factor-I axis in type 1 diabetes.

  2017cites this paper
• Circadian hormone profiles and insulin sensitivity in patients with Addison's disease: a comparison of continuous subcutaneous hydrocortisone infusion with conventional glucocorticoid replacement therapy

  2015cites this paper
• Behavioral Abnormalities in Lagotto Romagnolo Dogs with a History of Benign Familial Juvenile Epilepsy: A Long‐Term Follow‐Up Study

  2015cites this paper
• Pasireotide for the Medical Management of Feline Hypersomatotropism

  2015cites this paper
• Cushing’s disease: the clinical features, diagnostics, differential diagnostics, and methods of treatment

  2015cites this paper
• Serum extracellular secreted antagonists of the canonical Wnt/β-catenin signaling pathway in patients with Cushing’s syndrome

  2013influential citation
• The Endocrine Response to Critical Illness

  2013cites this paper
• Steroid myopathy: Some unresolved issues

  2011cites this paper
• Transgenic mice expressing the human growth hormone gene provide a model system to study human growth hormone synthesis and secretion in non-tumor-derived pituitary cells: differential effects of dexamethasone and thyroid hormone.

  2011cites this paper
• Previous chronic exogenous glucocorticoid administration in vivo does not affect functional characteristics and cellular lifespan of human skin fibroblasts in vitro

  2011cites this paper
• Mechanisms of Impaired Growth: Effect of Steroids on Bone and Cartilage

  2009cites this paper
• Insulin-like Growth Factor-I (IGF-I) Serum Concentrations in Depressed Patients: Relationship to Saliva Cortisol and Changes during Antidepressant Treatment

  2009cites this paper
• Use of desmopressin as an alternative to corticotropin-releasing hormone during inferior petrosal sinus sampling in a child with Cushing’s disease

  2007cites this paper
• Immunohistochemical localization of hormones and peptides in the human pituitary cells in a case of hypercortisolism by ACTH secreting microadenoma.

  2007cites this paper
• Prior Chronic in Vivo Glucocorticoid Excess Leads to an Anabolic Phenotype and an Extension of Cellular Life Span of Skin Fibroblasts in Vitro

  2007cites this paper
• IGF-I measurements in the diagnosis of adult growth hormone deficiency

  2007cites this paper
• The Unexpected Anabolic Phenotype and Extended Longevity of Skin Fibroblasts after Chronic Glucocorticoid Excess

  2006cites this paper
• Pituitary and mammary growth hormone in dogs

  2006cites this paper
• Secondary Cushing's syndrome after a single epidural injection of a corticosteroid.

  2005cites this paper
• Corticosteroid-serotonin interactions in depression: a review of the human evidence

  2004cites this paper
• Isolated Adrenocorticotropic Hormone (ACTH) Deficiency and Thyroid-Stimulating Hormone (TSH)-Thyroid Hormone Derangement: Report of Three Cases

  2004cites this paper
• Pulsatile secretion pattern of growth hormone in dogs with pituitary-dependent hyperadrenocorticism.

  2003cites this paper
• Influência dos glicocorticóides sobre o eixo somatotrófico

  2003cites this paper
• Brain and behavior interface: Stress and the developing brain

  2003cites this paper
• Chronic in vivo exposure to glucocorticoids prolongs cellular lifespan: the case of Cushing's syndrome-patients' fibroblasts.

  2002cites this paper
• Cortisol and GH secretory dynamics, and their interrelationships, in healthy aged women and men.

  2001cites this paper
• Effects of short-term administration of low-dose rhGH on IGF-I levels in obesity and Cushing's syndrome: indirect evaluation of sensitivity to GH.

  2001cites this paper
• Low cortisol and a flattening of expected daytime rhythm: Potential indices of risk in human development

  2001cites this paper
• Dexamethasone does not increase IGF-I and IGFBP-3 levels in man in the absence of endogenous GH

  2001cites this paper
• Regulatory circuits of the pituitary gland

  2001cites this paper
• IGFs and IGF-binding proteins in short children with steroid-dependent nephrotic syndrome on chronic glucocorticoids: changes with 1 year exogenous GH.

  2001cites this paper
• Recombinant human IGF-I does not modify the ACTH and cortisol responses to hCRH and hexarelin, a peptidyl GH secretagogue, in humans

  2001cites this paper
• Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome.

  2000cites this paper
• Effects of free fatty acids and acipimox, a lipolysis inhibitor, on the somatotroph responsiveness to GHRH in anorexia nervosa

  2000cites this paper
• Effect of hydrocortisone on the pituitary response to growth hormone releasing hormone

  2000cites this paper
• The Regulation of Growth Hormone Secretion

  1999cites this paper
• Molekulare Analyse des menschlichen „Growth Hormone Secretagogue”-Rezeptors

  1999cites this paper
• Growth hormone regulation of SOCS-2, SOCS-3, and CIS messenger ribonucleic acid expression in the rat.

  1999cites this paper
• IGF-I levels rise and GH responses to GHRH decrease during long-term prednisone treatment in man

  1999cites this paper
• [Molecular analysis of the human "growth hormone secretagogue"-receptor].

  1999cites this paper
• Structure and regulation of the human growth hormone-releasing hormone receptor gene.

  1998cites this paper
• Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human.

  1998cites this paper
• Different effects of growth hormone releasing peptide (GHRP‐6) and GH‐releasing hormone on GH release in endogenous and exogenous hypercortisolism

  1997cites this paper
• Effect of low-dose oral and intravenous dexamethasone administration on growth hormone secretion in children.

  1997cites this paper